“Congratulations on the 18th Congress. It was well conceived, well run, and well attended. From the Vaccine perspective, the major later stage development programs, shingles, RSV, influenza were coupled with opportunities for earlier stage programs to present and the major pharma companies to update. It was also extremely efficient for contacts, sharing in one and one and social settings, where some of the chief value of a conferences like this can be found. I also thought the related programs, cancer immunotherapy for example, fit in nicely and were again, well represented. Well done!”

Dr Gregory Glenn, President, Research and Development, Novavax


““Yours is one of the best-run conferences I attend. Good job.”

Dr Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine


“I know I speak for all my GSK colleagues when I say hats off to you and your Terrapinn colleagues. WVC was indeed outstanding this year.”

Jeffrey J. Stoddard, US Medical Affairs Lead, Zoster, Vaccines Clinical and Medical, US, GSK


“Congratulations on another successful WVC! I found it to be a very lively and informative event this year.”

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics


“I enjoyed the conference immensely. Both the quality of the presenters and the questions from the audience during my investor panel discussion were thoughtful and better informed than I have experienced in other events.”

Bernard Rudnick, Managing Partner, Capgenic Advisors


“I would like to express my sincere thanks on behalf of Enesi for this wonderful and now key event in our calendar. It is fair to say we overachieved all our objectives over the 4 days and our outcomes will have a lasting and material effect on the future of business our ambitions to become a key player in the global vaccine ecosystem.”

David Hipkiss, Chief Executive Officer, Enesi Pharma Limited


“The congress was great, and much better than I anticipated. Very well organized; lots of great presenters; good mix of industry, NGOs, government and academia; good symposia. I heard this from several people. I really don't have any suggestions for improvement!”

Dr Brad Gessner, VP for Scientific Affairs at AMP, Faculty at U. Maryland/Centers for Vaccine Development & VP and Director, Global Pneumococcal, Pfizer


“Congratulations! The meeting was first class with very good feedback by many attendees. Our dengue vaccine session was well attended and I had a lot of good comments on that session as well. It was a pleasure working with you on this.”

Dr Duane J Gubler, Emeritus Professor, Programme in Emerging Infectious Diseases, Duke-NUS Graduate Medical School


“I have attended the WVC for approx. 12 straight years and I do so with the affirmation of substantial value in learning opportunities from global luminaries as well as a very conducive atmosphere of business development and collaboration with industry partners. Kudos to the entire Terrapinn team in enthusiastically creating yet another over the top, WVC event!”

Werner Huck, Founder, Advanced Clinical Research (ACR)


“It was a very high quality and successful conference. Thanks for your effort. I am looking forward to work with you again!”

Li Shi, CEO, Shanghai Zerun Biotechnology Co. Ltd.


“This was a great meeting. Congratulations. Very well organized with great speakers and a balanced program.”

Prof Jorge Kalil, Prof of Clinical Immunology and Allergy, Past President os IUIS – International Union of Immunological Societies


“I was very pleased to participate in this congress. I found it most interesting and impressive on the SME that were in attendance. I learnt quite a bit and I found people were very engaging.”

Paddy Hanlon, VP Global Key Accounts, Marken


“I had a wonderful time in Washington. I met some old friends and found a few new ones with whom I have been in touch with since I got back to Geneva. You and your colleagues ran a really tight ship in Washington. Congratulations!”

James Cheyne, Independent Supply Chain Consultant Co-Founder of WHO's Cold Chain Unit, Health Service Logistics


“I really enjoyed it and had an opportunity to meet with many of my collaborators and friends.”

Dr Margie Danchin, Senior Research Fellow, Vaccine and Immunisation Research Group, Murdoch Children's Research Institute


"Largest scale of the any vaccine congress & various topic, good staff."

Manager, Greencross Korea

"Great opportunity to meet vaccine researchers, colleagues and vendors."

Associate Principal Scientist, Merck

“This conference is a very good way to get up to speed on the general field of vaccine development and connect with colleagues in the field.”

Vice President, Product Development, Aeras


“Strong attendance from many industry participants - quality content of presentations.”

Vaccine Supply Chain Director, Pfizer

“Always a well run conference with great science presented during the sessions, and the chance to meet with multiple decision makers in the field.”

CEO, Ology Bioservices

“Excellent organisation coupled with relevant mix of presentations and great opportunities to network.”

Senior Business Development Manager, Public Health England


“Well organized conference. Focus on the hottest topics. Great speakers. The organizer which was represented by a wonderful team of professional and talented members.”

Founder and Chief Executive Officer, ImmuneBiotech Ab

“A unique meeting focusing on vaccine and linking academia and industry. It would benefit everybody who are interested in vaccine development.”

Interim Associate Dean & Department Chair, University of Maryland, Baltimore

“Opportunity to network and meet directly with key decision makers.”

Process Services Director, Biodextris


"I've religiously attended the WVC annually nearly since inception. The WVC represents the compilation & orchestration of top global vaccine development leaders in a highly efficiently paced environment that creates individual and collective impact to further this highly impactful area of medicine."

Co Founder, President and Chief Scientific Officer, Epito Genesis Inc

"The congress brought together people and businesses active in animal and human health making it an excellent networking event."

Chief Development Officer & Co-Founder, ViroVet, Belgium

"Quality of the professionalism and administration of the conference by the organizers was very good. The talks and presentations were very good. The networking we achieved was very good."

VP Strategic Sales and Services, Meso Scale Diagnostics, LLC., United States


"Great opportunity to Network, Learn of new developments and trends of the industry and obtain Insights to the startegies companies are using to grow their business"

Director, GSK, United States

"WVC is a good opportunity to meet and discuss with vaccine experts."

Senior Manager,,Astellas Pharma Inc, Japan

"Probably the strongest conference in the vaccine sector"

Chief Executive Officer, Vaxart, United States


"Great meeting"


"It is the only conference with comprehensive coverage of vaccines including human and veterinary."

Chief General Manager, Manufacturing, Indian Immunologicals Ltd, India

"Very well organized, many contacts"

R&D Director, URODELIA, France


"Excellent conference for R&D colleagues"

VP, Scientific Affairs and Public Health Vaccines, North America, GSK, United States

"Quality, quality, quality of presentations and attendees"

Director, PATH, United States

"Very well organised, good networking opportunities"

Head of Clinical Regulatory Affairs, S.G.S. Life Science Services, Belgium

Sign Up for Event Updates